Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,915 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study).
Finke J, Schmoor C, Ayuk F, Hasenkamp J, Verbeek M, Wagner EM, Biersack H, Schäfer-Eckart K, Wolf D, Stuhler G, Reibke R, Schmid C, Kaufmann M, Eder M, Bertz H, Grishina O. Finke J, et al. Among authors: wolf d. Bone Marrow Transplant. 2024 Jul;59(7):936-941. doi: 10.1038/s41409-024-02264-9. Epub 2024 Mar 16. Bone Marrow Transplant. 2024. PMID: 38493275 Free PMC article. Clinical Trial.
Early autologous and/or allogeneic stem cell transplantation for adult patients with advanced stage T- lymphoblastic leukemia/lymphoma or Burkitt lymphoma. A retrospective single-centre analysis.
Steiner N, Baier K, Ritter D, Rudzki J, Hetzenauer G, Köck S, Kircher B, Gunsilius E, Wolf D, Nachbaur D. Steiner N, et al. Among authors: wolf d. Ann Hematol. 2024 Nov;103(11):4701-4705. doi: 10.1007/s00277-024-05979-3. Epub 2024 Sep 3. Ann Hematol. 2024. PMID: 39225777 Free PMC article.
Beta-2-Microglobulin Maintains Overall Survival Prediction in Binet A Stage Chronic Lymphocytic Leukemia Patients with Compromised Kidney Function in Both Treatment Eras of Chemoimmunotherapy and Targeted Agents.
Bohn JP, Stolzlechner V, Göbel G, Willenbacher W, Pirklbauer M, Steiner N, Wolf D. Bohn JP, et al. Among authors: wolf d. Cancers (Basel). 2024 Nov 6;16(22):3744. doi: 10.3390/cancers16223744. Cancers (Basel). 2024. PMID: 39594701 Free PMC article.
Identification and characterization of patients being exposed to computed-tomography associated radiation-doses above 100 mSv in a real-life setting.
Widmann G, Beyer A, Jaschke W, Luger A, Zoller H, Tilg H, Schneeberger S, Wolf D, Gizewski ER, Eder R, Torbica P, Verius M. Widmann G, et al. Among authors: wolf d. Eur J Radiol Open. 2022 Dec 21;10:100470. doi: 10.1016/j.ejro.2022.100470. eCollection 2023. Eur J Radiol Open. 2022. PMID: 36590327 Free PMC article.
Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial.
Flygt H, Söderlund S, Richter J, Saussele S, Koskenvesa P, Stenke L, Mustjoki S, Dimitrijevic A, Stentoft J, Majeed W, Roy L, Wolf D, Dreimane A, Gjertsen BT, Gedde-Dahl T, Ahlstrand E, Markevärn B, Hjorth-Hansen H, Janssen J, Olsson-Strömberg U. Flygt H, et al. Among authors: wolf d. Leukemia. 2024 Apr;38(4):781-787. doi: 10.1038/s41375-024-02145-6. Epub 2024 Jan 26. Leukemia. 2024. PMID: 38278960 Free PMC article.
Comparative analysis of 10X Chromium vs. BD Rhapsody whole transcriptome single-cell sequencing technologies in complex human tissues.
Salcher S, Heidegger I, Untergasser G, Fotakis G, Scheiber A, Martowicz A, Noureen A, Krogsdam A, Schatz C, Schäfer G, Trajanoski Z, Wolf D, Sopper S, Pircher A. Salcher S, et al. Among authors: wolf d. Heliyon. 2024 Mar 19;10(7):e28358. doi: 10.1016/j.heliyon.2024.e28358. eCollection 2024 Apr 15. Heliyon. 2024. PMID: 38689972 Free PMC article.
2,915 results